An article on Bloomberg yesterday announced what many in SPAC Land have been wondering after UBS acquired Credit Suisse – where was Niron Stabinsky, the Head of SPACs at Credit Suisse, going to land?
The answer is Banco Santander SA, in what appears to be a massive lift of most (or nearly all) of Credit Suisse’s banking team. Included in the group heading to Santander is David Hermer, who was Credit Suisse’s global head of equity and debt capital markets, and Steve Geller, who was head of mergers and acquisitions.
As for SPACs, Credit Suisse has always been a powerhouse SPAC bank, topping or ranking near the top of the league tables. More importantly, Niron Stabinsky and Credit Suisse underwrote and advised some of the biggest sponsor teams names which included Bill Foley, Chinh Chu, Barry Sternlicht, Tom Farley, and of course, Chamath Palihapitya, who is arguably the most recognizable name. All were guided by Stabinsky and the Credit Suisse team.
Meanwhile, Santander presents a unique opportunity for the former Credit Suisse team in that by being off the well worn path of the usual bulge bracket banks, they can move the entire banking group over without any of the usual conflicts of incumbent star bankers with existing franchises. That would be nearly impossible at any of the other more obvious banks.
This is a big win for Santander, which should be a big SPAC player going forward. Naturally, everyone will be on “garden leave” for a few months, but you can be sure to see the Santander name crop up in at least a few de-SPACs come this Fall.
Terms Tracker for the Week Ending October 25, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. Finally, a little more SPAC action this week with no less than four IPOs priced. That brings October’s tally to seven IPOs with one more...
At the SPAC of Dawn The rebound of the growth companies that made up the SPAC class of 2021 has been one of the bigger stories of second half of 2024, but not all of the de-SPACs are feeling the love equally. Instead, in many new sectors that hit the public markets together as a...
DT Cloud (NASDAQ:DYCQ) has entered into a definitive agreement to combine with Maius Pharmaceutical at an equity value of $250 million. Shanghai-based Maius is a drug developer and researcher focused on small-molecule chemical treatments for different forms of cancer. The combined company is expected to trade on the Nasdaq once the deal is completed in...
Charlton Aria Acquisition Corporation announced the pricing of its $75 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “CHARU”, Thursday, October 24, 2024. The new SPAC plans to focus on industries that complement the management team’s and board of director’s background and network. The sponsor team for...
At the SPAC of Dawn As the market goes through a cooling period this week, new readouts for jobless claims and new home sales are set to hit later today. Jobless claims are of course something of a proxy indicator for SPACs as to when the Fed might continue to its rate-cutting process, while home...